 There being no objection, the bill was ordered to be printed in the Record, as follows:                                S. 2968       Be it enacted by the Senate and House of Representatives of      the United States of America in Congress assembled,     SECTION 1. SHORT TITLE.       This Act may be cited as the ``Emergency Flu Response Act      of 2004''.     SEC. 2. EMERGENCY FLU RESPONSE.       Title XXI of the Public Health Service Act (42 U.S.C.      300aa-1 et seq.) is amended by adding at the end the      following:                    ``Subtitle 3--Influenza Vaccine     ``SEC. 2141. DEFINITION.       ``In this subtitle, the term `priority group' means a group      described as a priority group for vaccination with influenza      vaccine in recommendations entitled `Interim Influenza      Vaccination Recommendations - 2004-2005 Influenza Season',      dated October 5, 2004, or any successor to such      recommendations issued by the Secretary.     ``SEC. 2142. EMERGENCY ACCESS TO INFLUENZA VACCINE.       ``(a) Declaration of Emergency.--       ``(1) In general.--Under section 564(b)(1)(C) of the      Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360bbb-     3(b)(1)(C)), the Secretary shall immediately declare the      shortage of influenza vaccine in the United States for the      2004-2005 influenza season to be an emergency justifying an      authorization for a product under section 564 of such Act (21      U.S.C. 360bbb).       ``(2) Determination.--For the purpose of making      determinations under section 564(b)(1)(C) of such Act to      carry out paragraph (1), the Secretary--       ``(A) shall deem the shortage to be a public health      emergency described in such section; and       ``(B) shall deem influenza virus to be a biological agent.       ``(3) Construction.--Nothing in this subsection shall be      considered to invoke the authorities described in section      319, or to limit the ability of the Secretary to invoke such      authorities.       ``(b) Seeking Influenza Vaccine.--The Secretary shall      promptly consult with the health ministries of Canada,      countries that are members of the European Union as of      January 1, 2003, Japan, and Switzerland to assess the      availability of influenza vaccine for the 2004-2005 influenza      season that--       ``(1) has been approved, licensed, or otherwise cleared for      marketing by the relevant regulatory agency in such a      country; and       ``(2) is in excess of the needs in such country for the      vaccination of persons at high risk for complications from      influenza.       ``(c) Issuance of Authorization.--       ``(1) In general.--The Secretary shall promptly evaluate      available influenza vaccine (as identified under subsection      (b)) to determine whether the vaccine meets the criteria for      issuance of an authorization under section 564(c) of the      Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360bbb-3(c)).       ``(2) Criteria.--For the purpose of making determinations      under section 564(c) of such Act to carry out paragraph (1),      the Secretary--       ``(A) shall deem influenza virus to be an agent that can      cause a serious or life-threatening disease or condition; and       ``(B) shall deem the shortage described in subsection      (a)(1) to be sufficient evidence that there is no alternative      described in section 564(c)(3).       ``(d) Vaccine Purchase.--Not later than 30 days after the      date of enactment of the Emergency Flu Response Act of 2004,      the Secretary shall purchase, at a reasonable price,      available influenza vaccine identified under subsection (b)      for which the Secretary has issued an authorization under      section 564(c) of the Federal Food, Drug, and Cosmetic Act      (21 U.S.C. 360bbb-3(c)).       ``(e) Vaccine Distribution.--Notwithstanding any other      provision of law, the Secretary shall promptly import and      distribute any influenza vaccine purchased under subsection      (d), giving first priority to persons in priority groups.       ``(f) Authorization of Appropriations.--There are      authorized to be appropriated to carry out this section such      sums as may be necessary for fiscal year 2005.     ``SEC. 2143. EFFECTIVE RESPONSES TO VACCINE SHORTAGES.       ``(a) In General.--The Secretary shall award a grant to      each State to allow such State to develop and implement a      plan to respond to the shortage of influenza vaccine in the      United States for the 2004-2005 influenza season.       ``(b) Use of Funds.--A State that receives a grant under      this section shall use the funds made available through a      grant under subsection (a) to develop--       ``(1) a voluntary plan to ensure that the influenza vaccine      is, to the maximum extent possible, administered to priority      groups;       ``(2) a system to notify health care providers about      revisions in guidelines for administering influenza vaccine;       ``(3) an awareness campaign to inform the public about      recommendations concerning groups that are priority groups      for vaccination with influenza vaccine; and       ``(4) procedures to allow for the voluntary donation of      vaccine as described in section 2145.       ``(c) Amount.--The amount of a grant under subsection (a)      shall be proportional to the population of the State and the      severity of the shortage of influenza vaccine in such State,      as determined by the Secretary.       ``(d) Authorization of Appropriations.--There are      authorized to be appropriated to carry out this section such      sums as may be necessary for fiscal year 2005.     ``SEC. 2144. EFFECTIVE MONITORING OF THE NATION'S INFLUENZA                    VACCINE SUPPLY.       ``(a) Manufacturers.--Not later than 15 days after the date      of enactment of the Emergency Flu Response Act of 2004 and      every 30 days thereafter, any person who manufactures      influenza vaccine for introduction into interstate commerce      shall prepare and submit to the Secretary a summary report      that lists--       ``(1) each client, both public and private, who purchased      influenza vaccine from the manufacturer during the period      covered by the report; and       ``(2) the number of doses of influenza vaccine sold to each      client during the period.       ``(b) State Public Health Agencies.--To be eligible to      receive a grant under section 2143(a), a State through its      public health agency shall, not later than 15 days after the      date of enactment of the Emergency Flu Response Act of 2004      and every 30 days thereafter, prepare and submit to the      Secretary a summary report describing--       ``(1) the number of doses of influenza vaccine available in      the State during the period covered by the report;       ``(2) the number of such doses that were given to each      priority group during that period; and       ``(3) to the extent that such information is readily      obtainable by the State, the manner in which such doses were      distributed to consumers during such period, such as by      distribution through public health agencies or private health      care providers.     ``SEC. 2145. CLEARINGHOUSES FOR VOLUNTARY DONATION OF                    INFLUENZA VACCINE.       ``The Centers for Disease Control and Prevention, and each      State public health agency described in section 2144(b),      shall establish a clearinghouse to--       ``(1) enable persons to voluntarily donate influenza      vaccine doses; and       ``(2) distribute the doses for administration to      individuals in priority groups.     ``SEC. 2146. PURCHASES OF INFLUENZA VACCINE.       ``(a) In General.--The Secretary shall establish a program      through which the Secretary may--       ``(1) purchase from private employers, vaccine wholesalers,      and other appropriate individuals and entities, doses of      influenza vaccine that are not needed for the vaccination of      priority groups; and       ``(2) distribute the doses purchased under paragraph (1)      for administration to individuals in priority areas.       ``(b) Authorization of Appropriations.--There are      authorized to be appropriated to carry out this section such      sums as may be necessary for fiscal year 2005.     ``SEC. 2147. USE OF INFLUENZA VACCINE.       ``(a) Executive Branch.--The head of each Executive agency      (as defined in section 105 of title 5, United States Code)      shall ensure that any influenza vaccine in the possession of      the head of the agency shall--       ``(1) be administered only to employees of the agency who      are in priority groups; and       ``(2) provide to the Secretary any doses of the vaccine      that are not needed for the vaccination of individuals in      priority groups, so that the Secretary can distribute the      doses for administration to individuals in the priority      groups.       ``(b) Legislative Branch.--The Attending Physician of the      Capitol shall ensure that any influenza vaccine in the      possession of the Attending Physician shall--       ``(1) be administered only to employees of the legislative      branch of the Federal Government who are in priority groups;      and       ``(2) provide to the Secretary any doses of the vaccine      that are not needed for the vaccination of individuals in      priority groups, so that the Secretary can distribute the      doses for administration to individuals in the priority      groups.     ``SEC. 2148. ENHANCING EXISTING COUNTERMEASURES AGAINST                    INFLUENZA.       ``(a) Authorization to Purchase.--The Secretary may,      subject to amounts appropriated under subsection (d),      purchase at a reasonable negotiated price, such additional      amounts of any drug approved by the Commissioner of Food and      Drugs to treat influenza as are determined necessary by the      Secretary.       ``(b) Addition to Stockpile.--The Secretary shall include      any drug purchased under subsection (a) in the stockpile      established under section 121 of the Public Health Security      and Bioterrorism Preparedness and Response Act of 2002.       ``(c) Increasing the Effectiveness of Existing Vaccine      Supplies.--The Secretary, acting through the Director of the      National Institutes of Health, shall conduct a clinical trial      or trials to determine whether influenza vaccine can be      diluted and continue to retain its effectiveness in      preventing influenza in individuals in priority groups.       ``(d) Authorization of Appropriations.--There are      authorized to be appropriated to carry out this section such      sums as may be necessary for fiscal year 2005.     ``SEC. 2149. NATIONAL QUARANTINE COMPENSATION PROGRAM.       ``(a) In General.--There is established the National      Quarantine Compensation Program to be administered by the      Secretary under which compensation shall be paid to      individuals who are subjected to an order of quarantine      issued by a Federal or State health agency.       ``(b) Amount.--An individual's compensation under the      National Quarantine Compensation Program shall be equal to      wages lost as a result of such individual being subjected to      the quarantine.       ``(c) Appropriations.--There are authorized to be      appropriated and there are hereby appropriated to carry out      subsections (a) and (b) such sums as may be necessary.     ``SEC. 2150. EMPLOYMENT RIGHTS AND PROTECTIONS RELATING TO                    FEDERALLY MANDATED HEALTH-RELATED QUARANTINE.       ``(a) Definitions.--In this section:       ``(1) Employer.--The term `employer'--       ``(A) means any person engaged in commerce or in any      industry or activity affecting commerce; and       ``(B) includes--       ``(i)(I) any person who acts, directly or indirectly, in      the interest of a person described in subparagraph (A) to any      of the employees of such person; or       ``(II) any successor in interest of a person described in      subparagraph (A);       ``(ii) any public agency, as defined in section 3(x) of the      Fair Labor Standards Act of 1938 (29 U.S.C. 203(x));       ``(iii) the Government Accountability Office, the      Government Printing Office, and the Library of Congress; and       ``(iv) all other legislative branch entities identified as      employing offices in the Congressional Accountability Act of      1995 (2 U.S.C. 1301 et seq.).       ``(2) Employment benefits.--The term `employment benefits'      means all benefits provided or made available to employees by      an employer, including group life insurance, health      insurance, disability insurance, sick leave, annual leave,      educational benefits, and pensions, regardless of whether      such benefits are provided by a practice or written policy of      an employer or through an employee benefit plan, as defined      in section 3 of the Employee Retirement Income Security Act      of 1974 (29 U.S.C. 1002).       ``(3) Secretary.--       ``(A) In general.--Except as otherwise provided in      subparagraph (B), the term `Secretary' means the Secretary of      Labor.       ``(B) Exceptions.--In the case of actions brought regarding      employees--       ``(i) of the Government Accountability Office, the term      `Secretary' means the Comptroller General of the United      States;       ``(ii) of the Government Printing Office, the term      `Secretary' means the Public Printer;       ``(iii) of the Library of Congress, the term `Secretary'      means the Librarian of Congress; and       ``(iv) of any other legislative branch employer, the term      `Secretary' means the Office of Compliance.       ``(b) Employment Rights, Benefits, and Protection from      Discrimination.--       ``(1) Restoration to position.--Any individual subjected to      an order of quarantine issued by a Federal or State health      agency shall be entitled, on return from such quarantine--       ``(A) to be restored by the employer of such individual to      the position of employment held by the individual when the      quarantine of such individual commenced; or       ``(B) to be restored to an equivalent position with      equivalent employment benefits, pay, and other terms and      conditions of employment.       ``(2) Benefits.--An individual restored to such      individual's position, or equivalent position, pursuant to      paragraph (1) shall be entitled to the seniority and other      rights and benefits that the individual had on the date when      the quarantine of such individual commenced, plus the      additional seniority and rights and benefits that the      individual would have attained had the individual not been      subjected to a federally mandated health-related quarantine.       ``(3) Protection from discrimination.--It shall be unlawful      for an employer to discharge or in any other manner      discriminate against any individual on the basis of such      individual's being, or having been, subjected to a federally      mandated health-related quarantine.       ``(c) Investigative Authority; Enforcement.--       ``(1) In general.--The Secretary shall ensure compliance      with the provisions of subsection (b) and enforce violations      of subsection (b).       ``(2) Same authorities.--In order to carry out paragraph      (1), the Secretary shall have the same authorities as      provided to the Secretary under sections 106 and 107 of the      Family and Medical Leave Act of 1993 (29 U.S.C. 209 and 210)      to ensure compliance with and enforce violations of the      Family and Medical Leave Act of 1993.       ``(d) State and Local Laws.--Nothing in this section shall      be construed to supersede any provision of any State or local      law that provides greater rights than the rights established      under this section.''.     ``SEC. 2151. ASSURING THAT INDIVIDUALS IN PRIORITY GROUPS                    RECEIVE VACCINES.       ``(a) Determinations.--Not later than 30 days after the      date of enactment of the Emergency Flu Response Act of 2004,      and every 30 days thereafter, the Secretary shall review the      effectiveness of measures taken under sections 2142 through      2147 and determine whether the measures have ensured the      distribution of influenza vaccine for administration to      individuals in priority groups. If the Secretary determines      that the measures have not ensured that distribution, the      Secretary--       ``(1) may take the actions described in subsection (b) if      the Secretary determines that such actions are needed to      protect the public health; and       ``(2) shall notify the appropriate committees of Congress      of such determination.       ``(b) Assuring the Individuals in Priority Groups Receive      Vaccines.--On making the determination described in      subsection (a), the Secretary may require that a person, not      including a person that is a manufacturer of influenza      vaccine, who possesses influenza vaccine sell such person's      supply of the influenza vaccine to the Federal Government, as      an exercise of the Federal Government's power to take private      property for public use, for just compensation.       ``(c) Prioritization.--The Secretary shall distribute the      doses of influenza vaccine obtained under subsection (b) in a      manner determined appropriate by the Secretary to ensure that      such vaccine is administered to individual in priority      groups.''.  